info@afternoonnews.in +91 98940 - 95096

Today Date : Sunday, February 09, 2025

Lupin Digital Health unveils results of digital therapeutics study

Lupin Digital Health unveils results of digital therapeutics study

Lupin Digital Health (LDH), India's first evidence-based digital therapeutics platform, has unveiled the results of a first-of-its-kind study in India, showing the efficacy of digital therapeutics (DTx) among patients with acute coronary syndrome (ACS) and post-percutaneous coronary interventions. The study findings were presented at the India Live 2023 symposium in Chennai.

"As an interventional cardiologist, I am happy to see such positive and promising early results of the study, with more than 90% of patients adhering to the recommended medication, diet, and exercise regimen prescribed by us. By leveraging evidence-based technologies like digital therapeutics, we are revolutionising the way we deliver healthcare to our patients," said Dr. Abhijeet Palshikar, Interventional Cardiologist, Pune.

Sidharth Srinivasan said

"We are excited to share the positive outcomes of India's first digital therapeutics study. The study's outcomes showcase the effectiveness of our evidence-based and comprehensive heart care program in ensuring high adherence and low re-hospitalisation for patients,” said Sidharth Srinivasan, CEO, Lupin Digital Health. 

The study results indicate that digital therapeutics programs will have a crucial role in patient care across the cardiology continuum, powered by technology. These results showcase a promising future for remote patient care in cardiology, utilising the potential of digital health to improve patients' heart health.